1. Tyndall, AJ, Bannert, B, Vonk, M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69(10): 1809–1815.
Google Scholar | Crossref | Medline2. Steen, VD, Medsger, TA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis 2007; 66(7): 940–944.
Google Scholar | Crossref | Medline3. Le Pavec, J, Launay, D, Mathai, SC, et al. Scleroderma lung disease. Clin Rev Allergy Immunol 2011; 40(2): 104–116.
Google Scholar | Crossref | Medline4. Simonneau, G, Montani, D, Celermajer, DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53(1): 1801913.
Google Scholar | Crossref | Medline5. Komocsi, A, Vorobcsuk, A, Faludi, R, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology 2012; 51(6): 1027–1036.
Google Scholar | Crossref | Medline6. Champion, HC. The heart in scleroderma. Rheum Dis Clin North Am 2008; 34(1): 181–190; viii.
Google Scholar | Crossref | Medline7. Fisher, MR, Forfia, PR, Chamera, E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009; 179(7): 615–621.
Google Scholar | Crossref | Medline8. Rich, JD, Shah, SJ, Swamy, RS, et al. Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. Chest 2011; 139(5): 988–993.
Google Scholar | Crossref | Medline9. Badesch, DB, Champion, HC, Sanchez, MAG, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54(1 Suppl.): S55–S66.
Google Scholar | Crossref10. European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT) , Galiè, N, Hoeper, MM, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34(6): 1219–1263.
Google Scholar | Crossref | Medline11. Hao, Y, Thakkar, V, Stevens, W, et al. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Res Ther 2015; 17: 7.
Google Scholar | Crossref | Medline12. Thakkar, V, Stevens, W, Prior, D, et al. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Res Ther 2013; 15(6): R193.
Google Scholar | Crossref | Medline13. Chighizola, C, Meroni, PL, Schreiber, BE, et al. Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients. Clin Exp Rheumatol 2012; 30(2 Suppl. 71): S81–S85.
Google Scholar | Medline14. Kolto, G, Vuolteenaho, O, Szokodi, I, et al. Prognostic value of N-terminal natriuretic peptides in systemic sclerosis: a single centre study. Clin Exp Rheumatol 2014; 32(6 Suppl. 86): S75–S81.
Google Scholar | Medline15. Montagnana, M, Lippi, G, Volpe, A, et al. Evaluation of cardiac laboratory markers in patients with systemic sclerosis. Clin Biochem 2006; 39(9): 913–917.
Google Scholar | Crossref | Medline16. Avouac, J, Meune, C, Chenevier-Gobeaux, C, et al. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide. Arthritis Care Res 2015; 67(7): 1022–1030.
Google Scholar | Crossref17. Muangchan, C, Harding, S, Khimdas, S, et al. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group. Arthritis Care Res 2012; 64(9): 1405–1414.
Google Scholar | Crossref18. Alhajeri, H, Hudson, M, Fritzler, M, et al. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group. Arthritis Care Res 2015; 67(4): 582–587.
Google Scholar | Crossref19. Yancy, CW, Jessup, M, Bozkurt, B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62(16): e147–e239.
Google Scholar | Medline20. Hsu, VM, Moreyra, AE, Wilson, AC, et al. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 2008; 35(3): 458–465.
Google Scholar | Medline21. Steele, R, Hudson, M, Lo, E, et al. Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res 2012; 64(4): 519–524.
Google Scholar | Crossref | Medline22. Clements, P, Lachenbruch, P, Siebold, J, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22(7): 1281–1285.
Google Scholar | Medline23. Schafer, JL, Olsen, MK. Multiple imputation for multivariate missing-data problems: a data analyst’s perspective. Multivariate Behav Res 1998; 33(4): 545–571.
Google Scholar | Crossref | Medline